small molecule

BETAINE

BETAINE

Loss of exclusivityloss of exclusivity
CompanyEton PharmaceuticalsSee this company's full patent-cliff portfolio

Drug detail

Brand nameBETAINE
Active ingredientBETAINE
Strength1GM/SCOOPFUL
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2022
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BETAINE patent cliff — loss of exclusivity — | CliffBio